Blonanserin
What is Blonanserin?
Blonanserin (CAS 132810-10-7), also referenced under development codes AD-5423 and DSP-5423, is an atypical antipsychotic compound developed for the treatment of schizophrenia.
Where is Blonanserin used?
- CNS drug development: dopamine D2/D3 and serotonin 5-HT2A receptor antagonist
- Antipsychotic drug products: API or pharmaceutical intermediate for tablets and transdermal patches
- Generic drug development: reference standard or synthesis starting material for CNS formulations targeting schizophrenia
- Psychiatric drug discovery: receptor binding studies and comparative pharmacological profiling
- Medicinal chemistry: intermediate in the synthesis of structurally related heterocyclic compounds
Commercial specifications
- High-purity material, typically ≥98% by HPLC, suitable for API manufacturing and analytical reference use
- Packaging ranges from milligram-scale to kilogram lots
Other Names (Synonyms)
AQ316B4F8C|Lonasen